{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:57:41Z","timestamp":1779213461422,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","respiratoryinvestigation.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.resinv.2016.08.002","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T03:15:27Z","timestamp":1474254927000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases"],"prefix":"10.1016","volume":"55","author":[{"given":"Taisuke","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Tsuyuguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunobu","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shojiro","family":"Minomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Atagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihide","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2016.08.002_bib1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3201\/eid1403.061143","article-title":"Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City","volume":"14","author":"Bodle","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2016.08.002_bib2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJM198909283211304","article-title":"Infection with Mycobacterium avium complex in patients without predisposing conditions","volume":"321","author":"Prince","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2016.08.002_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccm.2011.09.001","article-title":"Lung cancer: epidemiology, etiology, and prevention","volume":"32","author":"Dela Cruz","year":"2011","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.resinv.2016.08.002_bib4","first-page":"691","article-title":"Clinical characteristics of pulmonary Mycobacterium avium complex infection complicated with lung cancer","volume":"89","author":"Hosoda","year":"2014","journal-title":"Kekkaku"},{"key":"10.1016\/j.resinv.2016.08.002_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1164\/rccm.201003-0503OC","article-title":"Pulmonary nontuberculous mycobacterial disease prevalence and clinical features","volume":"182","author":"Winthrop","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.08.002_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial disease","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.08.002_bib7","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/427329","article-title":"Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification","volume":"40","author":"Viscoli","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2016.08.002_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"Hayashi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.08.002_bib9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/JTO.0b013e31825abd49","article-title":"Association between pulmonary Mycobacterium avium complex infection and lung cancer","volume":"7","author":"Lande","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2016.08.002_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1513\/AnnalsATS.201303-062OC","article-title":"Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans","volume":"10","author":"Lee","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2016.08.002_bib11","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1164\/ajrccm.160.6.9902019","article-title":"Markers indicating deterioration of pulmonary Mycobacterium avium-intracellular infection","volume":"160","author":"Yamazaki","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.08.002_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/annrheumdis-2011-200690","article-title":"Mycobacterial diseases and antitumour necrosis factor therapy in USA","volume":"72","author":"Winthrop","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2016.08.002_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00408-013-9481-5","article-title":"Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea","volume":"191","author":"Lee","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2016.08.002_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/s10165-011-0577-6","article-title":"Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan","volume":"22","author":"Mori","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2016.08.002_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10156-002-0216-4","article-title":"Clinical analysis of pulmonary Mycobacterium avium complex disease in association with corticosteroid treatment","volume":"9","author":"Kobashi","year":"2003","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2016.08.002_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1164\/rccm.201107-1327OC","article-title":"Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia","volume":"185","author":"McCarthy","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.08.002_bib17","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","article-title":"Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections","volume":"175","author":"Patel","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.resinv.2016.08.002_bib18","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","article-title":"Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies","volume":"364","author":"Dorman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2016.08.002_bib19","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1001\/archinte.1997.00440410091010","article-title":"Mycobacteremia in patients with the acquired immunodeficiency syndrome","volume":"157","author":"Grinsztejn","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.resinv.2016.08.002_bib20","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2016.08.002_bib21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/1471-2407-14-770","article-title":"Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective study","volume":"14","author":"Hirashima","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2016.08.002_bib22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/clinids\/3.5.1028","article-title":"Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs","volume":"3","author":"Ahn","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.resinv.2016.08.002_bib23","first-page":"954","article-title":"A study of pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: identification and characterization of the mycobacteria","volume":"95","author":"Hobby","year":"1967","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.resinv.2016.08.002_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2016.08.002_bib25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/clinids\/18.5.736","article-title":"Rifampin-resistant Mycobacterium kansasii","volume":"18","author":"Wallace","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2016.08.002_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/0019-5359.30351","article-title":"Cytochrome P450 enzyme isoforms and their therapeutic implications: an update","volume":"61","author":"Kalra","year":"2007","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.resinv.2016.08.002_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-0711-5-3","article-title":"Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor","volume":"5","author":"Chen","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.resinv.2016.08.002_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10147-004-0394-4","article-title":"Potential interactions between irinotecan and rifampin in a patient with small-cell lung cancer","volume":"9","author":"Yonemori","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.resinv.2016.08.002_bib29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2165\/00003088-200544100-00005","article-title":"Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol","volume":"44","author":"Swaisland","year":"2005","journal-title":"Clin Pharmacokinet"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534516301010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534516301010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T09:26:56Z","timestamp":1536398816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534516301010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2212534516301010"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2016.08.002","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2016.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}